# Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease

> **NCT06203249** · — · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Microbiome
- Immune Function
- Anti-MDA5 Antibody Positive Dermatomyositis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06203249
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-20
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-11-25
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06203249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06203249, "Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06203249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*